Genome-wide relationship between R-loop formation and antisense transcription in Escherichia coli

Transcription termination by Rho is essential for viability in various bacteria, including some major pathogens. Since Rho acts by targeting nascent RNAs that are not simultaneously translated, it also regulates antisense transcription. Here we show that RNase H-deficient mutants of Escherichia coli exhibit heightened sensitivity to the Rho inhibitor bicyclomycin, and that Rho deficiency provokes increased formation of RNA-DNA hybrids (R-loops) which is ameliorated by expression of the phage T4-derived R-loop helicase UvsW. We also provide evidence that in Rho-deficient cells, R-loop formation blocks subsequent rounds of antisense transcription at more than 500 chromosomal loci. Hence these antisense transcripts, which can extend beyond 10 kb in their length, are only detected when Rho function is absent or compromised and the UvsW helicase is concurrently expressed. Thus the potential for antisense transcription in bacteria is much greater than hitherto recognized; and the cells are able to retain viability even when nearly one-quarter of their total non-rRNA abundance is accounted for by antisense transcripts, provided that R-loop formation from them is curtailed.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:46

Enthalten in:

Nucleic acids research - 46(2018), 7 vom: 20. Apr., Seite 3400-3411

Sprache:

Englisch

Beteiligte Personen:

Raghunathan, Nalini [VerfasserIn]
Kapshikar, Rajvardhan M [VerfasserIn]
Leela, Jakku K [VerfasserIn]
Mallikarjun, Jillella [VerfasserIn]
Bouloc, Philippe [VerfasserIn]
Gowrishankar, Jayaraman [VerfasserIn]

Links:

Volltext

Themen:

Bicozamycin
Bridged Bicyclo Compounds, Heterocyclic
DNA, Antisense
DNA Helicases
EC 3.1.26.4
EC 3.6.4.-
EC 5.99.-
J03U9E2P82
Journal Article
Research Support, Non-U.S. Gov't
Rho Factor
Ribonuclease H
UvsW protein, Bacteriophage T4
Viral Proteins

Anmerkungen:

Date Completed 22.07.2019

Date Revised 12.11.2023

published: Print

Citation Status MEDLINE

doi:

10.1093/nar/gky118

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM281326843